Bridge Biotherapeutics Statistics

Total Valuation

KOSDAQ:288330 has a market cap or net worth of KRW 233.56 billion. The enterprise value is 219.25 billion.

Market Cap	233.56B
Enterprise Value	219.25B

Important Dates

The last earnings date was Sunday, August 10, 2025.

Earnings Date	Aug 10, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:288330 has 82.82 million shares outstanding. The number of shares has increased by 38.20% in one year.

Current Share Class	82.82M
Shares Outstanding	82.82M
Shares Change (YoY)	+38.20%
Shares Change (QoQ)	+2.84%
Owned by Insiders (%)	5.13%
Owned by Institutions (%)	4.18%
Float	47.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20,894.10
PB Ratio	9.88
P/TBV Ratio	13.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.38
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.83

Financial Position

The company has a current ratio of 5.44, with a Debt / Equity ratio of 0.10.

Current Ratio	5.44
Quick Ratio	5.15
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.14
Interest Coverage	-97.94

Financial Efficiency

Return on equity (ROE) is -97.04% and return on invested capital (ROIC) is -50.65%.

Return on Equity (ROE)	-97.04%
Return on Assets (ROA)	-41.80%
Return on Invested Capital (ROIC)	-50.65%
Return on Capital Employed (ROCE)	-72.62%
Revenue Per Employee	319,373
Profits Per Employee	-550.53M
Employee Count	35
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.42% in the last 52 weeks. The beta is 2.07, so KOSDAQ:288330's price volatility has been higher than the market average.

Beta (5Y)	2.07
52-Week Price Change	+6.42%
50-Day Moving Average	2,180.16
200-Day Moving Average	3,592.50
Relative Strength Index (RSI)	56.02
Average Volume (20 Days)	2,470,663

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:288330 had revenue of KRW 11.18 million and -19.27 billion in losses. Loss per share was -428.51.

Revenue	11.18M
Gross Profit	-8.48M
Operating Income	-18.49B
Pretax Income	-19.39B
Net Income	-19.27B
EBITDA	-17.07B
EBIT	-18.49B
Loss Per Share	-428.51

Full Income Statement

Balance Sheet

The company has 17.92 billion in cash and 2.33 billion in debt, giving a net cash position of 15.59 billion or 188.29 per share.

Cash & Cash Equivalents	17.92B
Total Debt	2.33B
Net Cash	15.59B
Net Cash Per Share	188.29
Equity (Book Value)	23.65B
Book Value Per Share	428.70
Working Capital	15.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.09 billion and capital expenditures -990,000, giving a free cash flow of -17.09 billion.

Operating Cash Flow	-17.09B
Capital Expenditures	-990,000
Free Cash Flow	-17.09B
FCF Per Share	-206.38

Full Cash Flow Statement

Margins

Gross Margin	-75.86%
Operating Margin	-165,444.76%
Pretax Margin	-173,450.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:288330 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.20%
Shareholder Yield	n/a
Earnings Yield	-8.25%
FCF Yield	-7.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 29, 2024. It was a forward split with a ratio of 1.2.

Last Split Date	Jul 29, 2024
Split Type	Forward
Split Ratio	1.2

Scores

KOSDAQ:288330 has an Altman Z-Score of 9.05 and a Piotroski F-Score of 2.

Altman Z-Score	9.05
Piotroski F-Score	2